Related Experiment Video

Updated: Jun 22, 2026

Using the E1A Minigene Tool to Study mRNA Splicing Changes
10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

A truncated minimal-E1a gene with potency to support adenoviral replication mediates antitumor activity by

Lin Fang1, Yao Huang, Xiaocui Hu

  • 1Jiangsu Key Laboratory for Molecular and Medical Biotechnology, Nanjing Normal University, Nanjing, China.

Chemico-Biological Interactions
|June 16, 2009
PubMed

Insights

Researchers engineered a minimal E1a gene (mE1a) to enhance oncolytic adenovirus therapy. This modified virus effectively targets cancer cells, increasing apoptosis and antitumor efficacy while preserving normal cell function.

Area of Science:

  • Oncolytic virotherapy
  • Gene therapy
  • Cancer research

Background:

  • Oncolytic adenoviruses utilize the wild-type E1a gene (wE1a) for replication and antitumor effects.
  • Modifications to wE1a are crucial for enhancing efficacy and safety in cancer treatment.

Purpose of the Study:

  • To engineer a truncated minimal E1a (mE1a) gene to improve oncolytic adenovirus efficacy and safety.
  • To evaluate the antitumor potential of an adenovirus vector (AdDC315-mE1a) carrying the mE1a gene.

Main Methods:

  • Designed a 720-bp minimal E1a (mE1a) gene through deletions and mutations.
  • Constructed the AdDC315-mE1a vector using the hTERT promoter.
  • Assessed mE1a expression, viral replication, Neu protein levels, Rb binding affinity, cancer cell apoptosis, cell cycle arrest, and in vivo antitumor efficacy in hepatocarcinoma xenografts.

Main Results:

  • AdDC315-mE1a expressed mE1a in cancer cells, down-regulating Neu protein expression.
  • mE1a exhibited lower Rb binding affinity, preserving Rb tumor suppressive function.
  • Adenovirus replication was significantly enhanced in cancer cells (125- to 10,900-fold).
  • The mE1a-supported virus induced increased cancer cell apoptosis, cell cycle arrest, and superior antitumor effects in vivo.

Conclusions:

  • The truncated minimal mE1a gene functions as a tumor suppressor.
  • mE1a can be utilized to develop improved oncolytic adenovirus vectors for cancer gene therapy.

More Related Videos

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death13:54

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death

Published on: October 21, 2012

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.